Search For "monoclonal"
Monoclonal antibody cocktail unlikely to cause further mutations of COVID-
Updated : 5 years ago IST
New Delhi [India], May 30 (ANI): Monoclonal antibody cocktail, used for the treatment of COVID-19, is unlikely to lead to further mutation of the virus, said Dr Raman R Gangakhedkar, former Head Scientist of Epidemiology and Communicable Diseases at the Indian Council of Medical Research (IC
Read More
Efficient manufacturing system needed to lower cost of Monoclonal antibody
Updated : 5 years ago IST
New Delhi [India], May 30 (ANI): The cost of Monoclonal antibody therapy, which was recently approved by India's top drug regulatory body for treatment of COVID-19, can be lowered if a very efficient system for its manufacturing is developed, said Dr Nirmal K Ganguly, former Director-General
Read More
COVID-19: Indigenous monoclonal antibodies drug's production at low cost c
Updated : 5 years ago IST
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 5 years ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Fortis Escorts to administer monoclonal antibodies in Delhi
Updated : 5 years ago IST
New Delhi [India], May 26 (ANI): Fortis Escorts Heart Institute in Delhi is to administer dose of COVID-19 drug cocktail with fast-acting antibodies - Casirivimab and Imdevimab - from tomorrow.
Read More
First COVID-19 patient treated with antibodies cocktail in India discharge
Updated : 5 years ago IST
Gurugram (Haryana) [India], May 26 (ANI): An 84-year-old man from Haryana with multiple co-morbidities was discharged from Medanta hospital after getting the jap of monoclonal antibody cocktail. He has become the first person in India to be administered the COVID drug cocktail, which came i
Read More
US revokes authorisation of one of Eli Lilly's COVID-19 monoclonal antibod
Updated : 5 years, 1 month ago IST
Washington [US], April 17 (ANI): The US Food and Drug Administration (FDA) said on Friday that it has revoked it emergency authorisation of Eli Lilly's COVID-19 monoclonal antibody treatment bamlanivimab when used on its own.
Read More
US approves emergency use of Eli Lilly's antibody cocktail for COVID-19 tr
Updated : 5 years, 3 months ago IST
Washington [US], February 10 (ANI): The US Food and Drug Administration (FDA) has granted an emergency use authorization to a monoclonal antibody cocktail made by pharmaceutical company Eli Lilly for treating coronavirus patients at high risk of developing severe COVID-19.
Read More
Research shows Regeneron's COVID-19 antibody cocktail effective against co
Updated : 5 years, 4 months ago IST
New York [US], January 28 (ANI): The tests conducted on two different variants of the coronavirus show that one of the two monoclonal antibodies in Regeneron's cocktail therapy can neutralize both, despite the mutations, researchers reported on Wednesday.
Read More
Novel monoclonal antibody therapy cuts LDL cholesterol by half in high-ris
Updated : 5 years, 6 months ago IST
Washington [US], November 16 (ANI): The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 per cent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from th
Read More
Eli Lilly pauses COVID-19 treatment trial for Safety Reasons
Updated : 5 years, 7 months ago IST
Washington [US], October 14 (ANI/Sputnik): The US pharmaceutical company Eli Lilly's late-stage trial of its leading monoclonal antibody treatment for the novel coronavirus has been paused by health regulators over potential safety concerns, CNBC reported.
Read More
UK's AstraZeneca begins human trial of COVID-19 treatment using monoclonal
Updated : 5 years, 9 months ago IST
London [UK], Aug 25 (ANI/Sputnik): UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for COVID-19 using a combination of two monoclonal antibodies.
Read More